These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Treatment of Kratom Withdrawal and Addiction With Buprenorphine. Khazaeli A; Jerry JM; Vazirian M J Addict Med; 2018; 12(6):493-495. PubMed ID: 30383616 [TBL] [Abstract][Full Text] [Related]
26. Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period. Lembke A; Ottestad E; Schmiesing C Pain Med; 2019 Mar; 20(3):425-428. PubMed ID: 29452378 [No Abstract] [Full Text] [Related]
27. What interventions are effective to taper opioids in patients with chronic pain? Sandhu H; Underwood M; Furlan AD; Noyes J; Eldabe S BMJ; 2018 Sep; 362():k2990. PubMed ID: 30262590 [No Abstract] [Full Text] [Related]
28. Medically supervised taper for ultra high-dose opioids with significant comorbidities using a multidisciplinary approach: A case report. Wilkes D; Mitchell JM; Winden KJ; Parker D J Opioid Manag; 2022; 18(1):85-90. PubMed ID: 35238017 [TBL] [Abstract][Full Text] [Related]
30. [Tapering of opioid use in primary care]. Veldman SE; Vroon LC; Melis EJ; van den Heuvel SAS; Schellekens AFA; Kramers C Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34854610 [TBL] [Abstract][Full Text] [Related]
31. Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain. Nicholson B Postgrad Med; 2013 Jan; 125(1):115-27. PubMed ID: 23391677 [TBL] [Abstract][Full Text] [Related]
32. Ondansetron does not prevent physical dependence in patients taking opioid medications chronically for pain control. Chu LF; Rico T; Cornell E; Obasi H; Encisco EM; Vertelney H; Gamble JG; Crawford CW; Sun J; Clemenson A; Erlendson MJ; Okada R; Carroll I; Clark JD Drug Alcohol Depend; 2018 Feb; 183():176-183. PubMed ID: 29278818 [TBL] [Abstract][Full Text] [Related]
33. Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency. Oviedo-Joekes E; Marsh DC; Guh D; Brissette S; Schechter MT J Opioid Manag; 2011; 7(5):371-6. PubMed ID: 22165036 [TBL] [Abstract][Full Text] [Related]
34. Opioid Management: Initiating, Monitoring, and Tapering. Hooten WM Phys Med Rehabil Clin N Am; 2020 May; 31(2):265-277. PubMed ID: 32279729 [TBL] [Abstract][Full Text] [Related]
36. Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence. Higgins C; Smith BH; Matthews K Drug Alcohol Depend; 2018 Dec; 193():131-136. PubMed ID: 30368067 [TBL] [Abstract][Full Text] [Related]
37. Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients. Daitch D; Daitch J; Novinson D; Frey M; Mitnick C; Pergolizzi J Pain Med; 2014 Dec; 15(12):2087-94. PubMed ID: 25220043 [TBL] [Abstract][Full Text] [Related]
38. Review of perioperative pain management of opioid-dependent patients. Vadivelu N; Mitra S; Kai AM; Kodumudi G; Gritsenko K J Opioid Manag; 2016; 12(4):289-301. PubMed ID: 27575830 [TBL] [Abstract][Full Text] [Related]
40. States Move to Substitute Opioids With Medical Marijuana to Quell Epidemic. Voelker R JAMA; 2018 Dec; 320(23):2408-2410. PubMed ID: 30484825 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]